Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
carboplatin (paraplatin) (1 trial)
nivolumab (opdivo) (1 trial)
oregovomab (3 trials)
paclitaxel (taxol) (1 trial)
poly-iclc (1 trial)
Carcinoma, Ovarian Epithelial (Phase 2)
Ovarian Neoplasms (Phase 2)
Trials (3 total)
Trial APIs (5 total)